# TTFields Plus FET-PET-Guided Stereotactic Radiosurgery Versus TTFields Alone for Recurrent Glioblastoma (Tarrget 2.0)

> **NCT07668869** · NA · RECRUITING · sponsor: **Prof. Franciszek Lukaszczyk Memorial Oncology Center** · enrollment: 92 (estimated)

## Conditions studied

- Glioblastoma
- Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
- Glioblastoma Multiforme, Adult

## Interventions

- **DEVICE:** Tumor Treating Fields (TTFields)
- **RADIATION:** FET-PET-Guided Stereotactic Radiosurgery

## Key facts

- **NCT ID:** NCT07668869
- **Lead sponsor:** Prof. Franciszek Lukaszczyk Memorial Oncology Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-30
- **Primary completion:** 2030-06
- **Final completion:** 2032-06
- **Target enrollment:** 92 (ESTIMATED)
- **Last updated:** 2026-06-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07668869

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07668869, "TTFields Plus FET-PET-Guided Stereotactic Radiosurgery Versus TTFields Alone for Recurrent Glioblastoma (Tarrget 2.0)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07668869. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*